中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2026-06-302026-03-312025-12-312025-09-302025-06-30
营业总收入(万元)21130.379250.2237834.3627155.3618189.98
营业收入(万元)21130.379250.2237834.3627155.3618189.98
营业总成本(万元)23926.1310790.5046308.1131578.3320228.37
营业成本(万元)17019.466997.5127854.7019182.2012512.67
净利润(万元)-2796.08-1050.97-6834.34-3016.11-1828.05
归属于母公司的净利润(万元)-2796.08-1050.97-6966.10-3016.11-1828.05
营业利润(万元)-2867.30-1342.74-7175.75-3635.82-2105.58
利润总额(万元)-2867.93-1345.97-7238.54-3650.96-2143.13
少数股东损益(万元)----------
基本每股收益(元)-0.22(元)-0.08(元)-0.55(元)-0.24(元)-0.14(元)
稀释每股收益(元)-0.22(元)-0.08(元)-0.55(元)-0.24(元)-0.14(元)
非经常性损益(万元)--148.88--578.18--
扣除非经常性损益后净利润(万元)-3067.64-1199.85-7893.81-3594.28-2220.76
总资产(万元)163231.23165097.04166529.64168936.52170723.00
总负债(万元)17398.8217607.2218111.9716700.6217299.05
归属于母公司股东权益合计(万元)145832.41147489.82148417.67152235.90153423.95
股东权益合计(万元)145832.41147489.82148417.67152235.90153423.95
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)63981.1365726.2466777.2170727.2071915.26
经营活动产生的现金流量净额(万元)-455.15-140.95-2618.69-2278.96-2301.46
经营活动现金流入小计(万元)17215.458368.0231023.8124574.2016104.68
经营活动现金流出小计(万元)17670.618508.9733642.5026853.1618406.14
投资活动产生的现金流量净额(万元)-3249.60846.957054.062434.031898.12
投资活动现金流入小计(万元)21109.517534.7498499.5572891.1647257.88
投资活动现金流出小计(万元)24359.116687.7991445.4970457.1345359.76
筹资活动产生的现金流量净额(万元)9.185.18-121.00-122.42--
筹资活动现金流入小计(万元)9.185.181.42----
筹资活动现金流出小计(万元)----122.42122.42--
期末现金及现金等价物余额(万元)6716.0611145.9110463.756195.395787.99
最后修改日期2026-08-272026-04-282026-03-282025-10-292025-08-27
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。